NPR's Michel Martin speaks with Jennifer Klein, director of the White House Gender Policy Council, on the new $12 billion initiative on women's health research, signed by President Biden on Monday.

Since Inauguration Day, the Trump administration has repeatedly frozen and terminated research funding for seemingly political reasons. Federal agencies have ended grants for studies because they ...

President Donald Trump’s recent executive order, which requires a “senior appointee” or “designee” to approve only those federal grants that match the president’s policy priorities, federal agency ...

America’s scientific enterprise stands at a crossroads. Late Thursday, President Donald Trump signed an executive order granting political appointees sweeping authority over the billions of dollars in ...

On Thursday, the Trump administration issued an executive order asserting political control over grant funding, including all federally supported research. The order requires that any announcement of ...

US President Donald Trump issued an expansive executive order (EO) yesterday that would centralize power and upend the process that the US government has used for decades to award research grants. If ...

SAN DIEGO — President Donald Trump has signed an executive order to move the process along to reclassify cannabis from a Schedule One drug to a Schedule Three controlled substance, a move that could ...

Marijuana would still not be legal; the change could allow more studies on cannabis and CBD. HealthDay News — President Donald Trump signed an executive order Thursday that could make it easier for ...

An executive order signed Thursday by President Donald Trump would reclassify marijuana as a controlled substance with potential medical use — a designation that will make it easier for the Department ...

The White House is holding up President Donald Trump’s executive order directing federal agencies to complete the process of ...

WASHINGTON — President Donald Trump signed an executive order Thursday to speed the reclassification of marijuana from a Schedule I drug, a significant change that would not federally legalize ...